Invests in
Locations:
Min Investment:
$100,000.00Max Investment:
$5,000,000.00Target Investment:
$1,500,000.00
Skills
Education
Certificate in Corporate DIrection (Corporate Governance, Finance, Strategy, Leadership)
Bachelor of Science - BSc (Hons)
- Ysgol Gymraeg Llundain
Lists including Melya
Work Experience
Managing Director
2010
Company Building, Corporate Development, Strategy, Investment
2015 - 2023
Partner
2015 - 2023
Ventac Partners work to advance healthcare and biotechnology innovations and create the maximum value for inventors and investors. We offer proven CEO and Board Member experience and assistance to start-up biotechnology businesses and IPO candidates.
2017 - 2019
Non Executive Director
2017 - 2019
LSHW is a company limited by guarantee and a wholly-owned subsidiary of the Welsh Government, supporting engagement from the public and private sector to develop opportunities for improved health and wellbeing.
2011 - 2013
Founder & CEO
2011 - 2013
Caltherix Inc. - microprotein therapeutics addressing GPCRs and ion channel targets in pain and oncology
2005 - 2010
Chief Executive Officer (US) and Executive Management (CH)
2005 - 2010
President & CEO, Genetic Chemistry Inc. (Evolva US) (May 2008- June 2010) Founder, Genetic Chemistry Inc. (Evolva US) (April 2007- April 2008) VP Alliances & IP, Evolva SA (March 2005 - April 2008) Evolva/Genetic Chemistry Inc. was focused on synthetic biology approaches to discover and develop small molecule therapeutics (anti-infectives).
2004 - 2005
Business & IP Strategy Consultant
2004 - 2005
1999 - 2003
Head of Licensing & Patents
1999 - 2003
The FMI (Novartis Research Foundation) is a center for biomedical research with about 20 research groups and over 250 staff, with focus areas including oncology, metabolic disease, neurosciences, epigenetics and agribusiness.
1998 - 1999
Patent Counsel
1998 - 1999
Geron focused on stem cell therapies and inhibition of telomerase (oncology).
1993 - 1998
Patent Agent
1993 - 1998
1990 - 1992
Research Scientist
1990 - 1992